Contact Us
Schedule a free and confidential case review today.
Top News
Man on Ruxolitinib Develops PML
The drug ruxolitinib, used to treat intermediate or high risk myelofibrosis, has been associated with the development of progressive multifocal leukoencephalopathy... read more
Preliminary Data Show Catching PML Early May Prevent Death
If patients with progressive multifocal leukoencephalopathy (PML) are diagnosed using magnetic resonance imaging before symptoms of the disease appear, their chances... read more
New Drug for Hodgkin Lymphoma Has Been Fatal for PML Patients
ADCETRIS™ (generic name: brentuximab vedotin) is a new drug for treating Hodgkin Lymphoma (HL). On March 26, 2012, the makers of... read more